Below you'll find a list of all posts that have been categorized as “Podcast”
BigMike Straumieitis is the Since 1983, BigMike Straumieitis has worked tirelessly to find new ways to bring cannabis to its true genetic potential—legally and illegally. He’s overseen the cultivation of over a million pot plants over the course of his career. in 1999, BigMike founded Advanced Nutrients, the first fertilizer company with products specifically designed for cannabis plants. Today, Advanced …
Kevin McKernan is Chief Scientific Officer at Medicinal Genomics. Kevin is back to talk about Psilocybin and the mushrooms that create it. Kevin and the team at MGC have published a highly contiguous reference genome for Psilocybe cubensis, which some listeners may know is the species of mushroom often referred to as the magic mushroom. Kevin and the team have …
William Vizuete, PhD is Chief Scientific Officer for Byers Scientific where he analyzes cannabis and hemp plant emissions and helps to develop state-of-the-art odor and emission mitigation solutions and equipment. For the past six years, Dr. Vizuete has led a team of cannabis industry experts focused on site-specific research to increase overall knowledge of cannabis industry emissions, educate local communities, …
Dr. Michelle Shuffett is an accomplished healthcare executive, marketing strategist, speaker, and wellness enthusiast with 20+ years of experience encompassing a unique blend of clinical medicine, communications, and leadership. Much of her recent work has been in the cannabis industry, highlighting the potential health benefits of cannabis and CBD. She recently joined Radicle Science as a founding team member and Chief Growth Officer. At its core, …
Greg Gerdeman, PhD is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system. Recently, Greg has gotten involved in the conversation around Delta-8 THC. He comes at the topic from a neuroscientist’s perspective questioning how much we know about how Delta-8 THC affects the body and the brain. He also raises important questions …
Alice Moon is a PR and marketing professional who has worked in the cannabis space since 2011. In 2018, Alice was diagnosed with Cannabinoid Hyperemesis Syndrome, a condition that leads to repeated and severe bouts of vomiting when she consumes cannabinoids. Since being diagnosed with CHS, Alice has ceased cannabis use completely and become an advocate for safe and mindful …
Dr. Debra Kimless is the CMO of Pure Green Pharmaceuticals, where she oversees clinical medical testing, patient and physician educational programs, and medical product development. Deb and her team recently published an open-label clinical trial for treating diabetic neuropathic pain with a water-soluble CBD tablet. In our conversation we discuss: Results from her clinical trial for treating diabetic neuropathic pain with …
Dr. Peter Grinspoon is a primary care physician at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. He is a Contributing Editor to Harvard Health Publications and the Harvard Health Blog, where he frequently writes about cannabis medicine issues. Dr. Grinspoon also writes about addiction, both from the perspective of a clinician treating the disorder and as someone …
We discuss dosing medical cannabis with Dr. Dustin Sulak. Dustin is an osteopathic general practitioner who focuses on treating patients with refractory conditions using an individualized, health-centered approach. Dr. Sulak is a founder of Integr8 Health, a medical practice in Maine that follows over 8,000 patients using medical cannabis, and cofounder of Healer.com, a medical cannabis education resource. Dustin has …
We discuss the chemistry of cannabis with Markus Roggen, PhD. In his various roles and positions, Dr. Roggen oversaw multiple teams that are focused on the whole processing flow of cannabis production, from harvest and drying, through processing and extraction, all the way to the formulation and quality control/analytics. In addition to cannabinoids, Dr. Roggen’s company, Complex Biotech Discovery Ventures …
